[1] Kim J,Coffey DM,Creighton CJ,et al.High-grade serous ovarian cancer arises from fallopian tube in a mouse model［J］.Proc Natl Acad Sci,2012,109(10):3921-3926.
[2] Nam EJ,Yoon H,Kim SW,et al.MicroRNA expression profiles in serous ovarian carcinoma［J］.Clin Cancer Res,2008,14(9):2690-2695.
[3] Li Y,Yao L,Liu F,et al.Characterization of microRNA expression in serous ovarian carcinoma［J］.Int J Mol Med,2014,34(2):491-498.
[4] Di Leva G,Croce CM.The role of microRNAs in the tumorigenesis of ovarian cancer［J］.Frontiers in Oncol,2013,3:153-162.
[5] Kinose Y,Sawada K,Nakamura K,et al.The role of microRNAs in ovarian cancer［J］.Bio Med Res Int,2014,10:1-11.
[6] H Hermeking.The miR-34 family in cancer and apoptosis［J］.Cell Death and Differerntiation,2010,17(2):193-199.
[7] Tang W,Jiang Y,Mu X,et al.MiR-135a functions as a tumor suppression in epithelial ovarian cancer and regulates HOXA10 expression［J］.Cellular Signalling,2014,26(7):1420-1426.
[8] Thiery JP,Acloque H,Huang R,et al.Epithelial-mesenchymal transitions in development and disease［J］.Cell,2009,139(5):871-890.
[9] Wang Y,Yan S,Liu X,et al.miR-1236-3p represses the cell migration and invasion abilities by targeting ZEB1 in high-grade serous ovarian carcinoma［J］.Oncol Rep,2014,31(4):1905-1910.
[10] Hu X,Macdonald DM,Huettner PC,et al.A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer［J］.Gynecol Oncol,2009,114(3):457-464.
[11] Tang H,Yao L,Tao X,et al.miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1［J］.Int J Mol Med,2013,32(2):381-388.
[12] Yuan J,Wang K,Xi M,et al.MiR-494 inhibits epithelial ovarian cancer growth by targeting c-Myc［J］.Med Sci Monitor,2016,22:617-624.
[13] Wang W,Ren F,Wu Q,et al.MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer［J］.Oncol Rep,2014,32(5):2127-2133.
[14]Lei Lei，Wang Yanli，Liang Jing，et al.Identification of differentially expressed microRNAs in epithelial ovarian cancer［J］.Modern Oncology,2013,21(2):398-402.
[15] McMillen B,Aponte M,Liu Z,et al.Expression analysis of MIR182 and its associated target genes in advanced ovarian carcinoma［J］.Mod Pathol,2012,25(12):1644-1653.
[16] Liu Z,Liu J,Segura M,et al.MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma［J］.J Pathol,2012,228(2):204-215.
[17] Wu A,Huang Y,Zhang L,et al.MiR-572 prompted cell proliferation of human ovarian cancer cells by suppressing PPP2R2C expression［J］.Biomed & Pharmacotherapy,2016,77:92-97.
[18] Zhao H,Bi T,Qu Z,et al.Expression of miR-224-5p is associated with the original cisplatin resistance of ovarian papillary serous carcinoma［J］.Oncol Rep,2014,32(3):1003-1012.
[19] Liu Z,Gersbach E,Zhang X,et al.miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma［J］.Mol Cancer Res,2013,11(11):1314-1325.
[20] Ye G,Fu G,Cui S,et al.MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7:Implications for chemoresistance［J］.J Cell Sci,2011,124(3):359-368.
[21] Weiner-Gorzel K,Dempsey E,Milewska M,et al.Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells［J］.Cancer Med,2015,4(5):745-758.
[22] Guo F,Tian J,Cui M,et al.Serum microRNA-92 expression in patients with ovarian epithelial carcinoma［J］.J Int Med Res,2013,41(5):1456-1461.
[23] Ayaz L,Cayan F,BaLci S,et al.Circulating microRNA expression profiles in ovarian cancer［J］.J Obst Gynaecol,2014,34(7):620-624.